Australia's most trusted
source of pharma news
Monday, 30 March 2026
Posted 30 March 2026 AM
A top respiratory specialist has described Australia's treatment guidelines for COPD as an "escalator to failure” necessitating multiple hospitalisations or attacks before a patient can receive more treatment.
Dr Sanjay Ramakrishnan who presented at the Thoracic Society ANZ Conference in Perth over the weekend said the current Australian COPD treatment guidelines were “not in sync with the rest of the world".

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.